Andrew Chadeayne (@AndrewChadeayne) profile picture

CEO at CaaMTech

Joined September 2021
Andrew Chadeayne retweeted
New pub out now in @ACSChemNeurosci comparing 5-HT1A & 5-HT2A activities of #5MeODMT analogs #psychedelics pubs.acs.org/doi/full/10.102…
1
1
5
1,018
Andrew Chadeayne retweeted
CaaMTech’s new clinical trial design solves the emergent functional unblinding problems plaguing #psychedelic medicine developers caam.tech/fda-blesses-caamte…
1
143
Andrew Chadeayne retweeted
Psilacetin is More Potent than Psilocybin: @CaaMTechInc, @NIDAnews, @usonainstitute, @ResearchUGent, @UMassD and @UWyonews researchers directly compared #psilocybin with understudied #magicmushroom molecules, and synthetic analogs such as psilacetin caam.tech/psilacetin-is-more…
3
7
Andrew Chadeayne retweeted
New article out now regarding the pharmacology of #psilocybin analogues including other compounds found in psilocybin-containing mushrooms, their active metabolites, and 4-acetoxy derivatives. pubs.acs.org/doi/10.1021/acs… #pharmacology #psychedelics #aeruginascin #baeocystin
4
18
3
48
I'd love to see a study on psychedelics treating long COVID, there are some insane case reports
10
39
6
258
CaaMTech Creates Two New Prodrugs of 4-HO-DiPT CaaMTech scientists, in collaboration with the Manke Lab at UMass Dartmouth, recently reported their synthesis and structural characterization of two novel #psychedelics #StocksToBuy #trading https://teapawt.net/t.co/U5T1QqdrMF
Andrew Chadeayne retweeted
One of the most popular podcast episodes I've done this year was w/ @AndrewChadeayne, CEO of biotech startup @CaaMTechInc. We did a fairly deep dive into the chemistry & pharmacology of tryptamine #psychedelics, e.g. psilocybin, DMT. Listen here: mindandmatter.substack.com/p…
2
4
Andrew Chadeayne retweeted
1
2
1
8
Andrew Chadeayne retweeted
“It is an honor for us to carry on Dr. Alexander Shulgin’s legacy,” said Dr. @AndrewChadeayne, CEO of CaaMTech. “The current state of this industry is possible only because we’re standing on the shoulders of giants such as Alexander Shulgin.” caam.tech/caamtech-collabora…
5
14
Andrew Chadeayne retweeted
New paper about synthesis, structural characterization, & pharmacological activity of aeruginascin analogs with @AndrewChadeayne of @CaaMTechInc & a bunch of twitterless co-authors is out now! 👇 pubs.acs.org/doi/10.1021/acs…
4
18
Andrew Chadeayne retweeted
M&M #71 goes live Thurs, all about the chemistry of #psilocybin mushrooms + entourage effects in #cannabis and magic mushrooms. Fascinating discussion with chemist @AndrewChadeayne, CEO of @CaaMTechInc. Early access: mindandmatter.substack.com/p…
1
2
1
4
Andrew Chadeayne retweeted
Why do magic mushrooms turn blue when damaged? Why do they produce psilocybin in the first place? What other compounds, beyond psilocybin, can be found in these fungi. Clip from my conversation with chemist @AndrewChadeayne from @CaaMTechInc. Watch here: youtube.com/watch?v=aJ2djiV0…
1
3
8
Andrew Chadeayne retweeted
Our recent paper in @npp_journal re SARs for cannabinoid-like effects of 5F-MDMB-PICA and 5F-pentylindole analogs in mice is featured as the NIDA IRP paper of the month 🙌😎 👇 irp.drugabuse.gov/featured-p…
1
5
14
Andrew Chadeayne retweeted
Psychedelic science opportunity🚨 We at @JHPsychedelics are hiring a postdoc who will work with me & Roland Griffiths. Having gone through the postdoc program myself, I can vouch for the the excellent scientific training and wonderful people at the lab. Please share widely!
3
55
3
110
Losing these chemicals would be a terrible blow to pharmacology, DOI is one of the most widely used 5HT2A agonists in scientific research, it's featured in close to two thousand scientific publications.
2
44
1
192